Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Rocunova - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Rocunova

Approved

STANDARD

Rocunova

Immacule Lifesciences Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 005cecc2c7c4e324
Company: Immacule Lifesciences Private Limited
Type: Standard

Approval Details

Approval Id: 005cecc2c7c4e324
Drug Approval Philippines Name: Rocunova
Product Name: Rocunova
Registration Number: DRP-10626
Brand Name: Rocunova
Generic Name: Rocuronium Bromide
Dosage Form: Solution for Injection (IV)
Dosage Strength: 10 mg/mL
Manufacturer: Immacule Lifesciences Private Limited
Importer: Medinova Pharmaceutical Inc.
Distributor: Medinova Pharmaceutical Inc.
Company Detail Path: /organization/immacule-lifesciences-private-limited
Issuance Date: 03 November 2021
Expiry Date: 03 November 2026
Pharmacologic Category: Muscle Relaxant
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

005cecc2c7c4e324

Type

Standard

Back to Philippines FDA Approvals